Veoli

Company Overview

Snapshot

Founded in December 2018 by Tzur Di-Cori, Veoli operates with 1–10 employees. The company has secured capital across two funding rounds from two investors. In August 2019, Merchavia Holdings invested in the company, highlighting its focus on medical cannabis delivery.

Business overview

Veoli is developing an innovative inhaler designed for the precise delivery of cannabis oil without heat, evaporation, or burning. Its core technology converts liquid into micron-sized droplets for pulmonary absorption, preserving the cannabis properties and avoiding byproducts. The device integrates with smartphones for remote quantity control by medical teams, serving the health tech and life sciences sectors, particularly in medical cannabis and drug delivery.

Strategic signal

In August 2019, Merchavia Holdings completed an investment in Veoli, as reported by en.globes.co.il. This investment signals continued investor interest in the medical cannabis and drug delivery space, validating Veoli's approach to providing a controlled and heat-free cannabis oil inhalation method. For investors, this indicates a strategic move to support companies developing advanced solutions for medical treatment and therapeutics.

Company Intelligence Q&A

What is Veoli's primary product?

Veoli's primary product is an inhaler designed to deliver cannabis oil at an accurate dosage without the need for heat, evaporation, or burning, converting liquid into micron-sized droplets for inhalation.

When was Veoli founded and by whom?

Veoli was founded in December 2018 by Tzur Di-Cori.

Which investor participated in Veoli's August 2019 funding round?

In August 2019, Merchavia Holdings participated in a funding round for Veoli.

Which investor participated in Veoli's March 2019 funding round?

In March 2019, Sanara Ventures participated in a funding round for Veoli.

What is the current status of Veoli?

Veoli is currently non-active, having ceased to operate in August 2021.